Resumen
Introduction Kidney cancer represents 2.4% of diagnosed cases of cancer in the general population; it is more common in men than in women, and occurs more frequently between the 6th and 8th decades of life. It is estimated that 16% of patients are diagnosed as metastatic disease. Objective To report the case of a male patient whose diagnosis of renal carcinoma was initially misdiagnosed as a benign tumor. Methods We present a 56-year-old male diagnosed three years back with malignancy at an advanced stage of the disease, despite the incidental finding of a tumor that for 5 years was considered benign. Results At the time of diagnosis of clear cell carcinoma, the tumor was Stage IV, with lung metastasis. He received first line treatment with sunitinib, which was discontinued due to toxicity. Subsequently, a second line with pazotinib for 1 year, then presented progression of the disease, so treatment was changed to axitinib with partial response., It was discontinued, however, due to cardiac toxicity, among others. At the time of writing, the patient has received 5 cycles of bevacizumab with adequate tolerance. Conclusions It is necessary to highlight the need for adequate diagnosis and surgical management in suspicious renal masses.
Título traducido de la contribución | Benign Kidney Tumor versus Renal Carcinoma: Case report and literature review |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 30-34 |
Número de páginas | 5 |
Publicación | Urologia Colombiana |
Volumen | 28 |
N.º | 1 |
DOI | |
Estado | Publicada - 2019 |
Palabras clave
- angiomyolipoma
- axitinib
- bevacizumab
- carcinoma
- diagnosis
- differential
- kidney neoplasms
- pazopanib
- renal cell
- sunitinib